Congenital Toxoplasmosis: Clinical Trials

2 trials for Congenital Toxoplasmosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow Congenital Toxoplasmosis: new trials by email Literature Review of Congenital Toxoplasmosis trials Research Report on Congenital Toxoplasmosis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Pyrimethamine/Sulfadiazine, Spiramycine - Congenital Toxoplasmosis
Phase 3CompletedAssistance Publique - Hôpitaux de Paris1492010-11-012016-09-29
Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
reducing treatment to 3 months, registered length of treatment - Congenital Toxoplasmosis
Phase 3TerminatedCentre Hospitalier Universitaire Dijon3022010-07-282024-02-22

Narrower conditions

Toxoplasmosis, Congenital (2)

Broader conditions

Central Nervous System Diseases (2)  ·  Central Nervous System Infections (2)  ·  Central Nervous System Parasitic Infections (2)  ·  Central Nervous System Protozoal Infections (2)  ·  Coccidiosis (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Infant, Newborn, Diseases (2)  ·  Infections (2)  ·  Nervous System Diseases (2)  ·  Parasitic Diseases (2)  ·  Protozoan Infections (2)  ·  Toxoplasmosis (2)

Interventions

Pyrimethamine (1)  ·  Spiramycin (1)  ·  Sulfadiazine (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Universitaire Dijon (1)

Countries

France (2)

Top investigators

Laurent Mandelbrot, MD (1)

NIH funding

2009 (1)